Comparison

Human CD274/PD-L1 protein, His tag (Animal-Free)

Item no. ABK-PRP2021-10ug
Manufacturer Abbkine Scientific
Amount 10 ug
Quantity options 100 ug 10 ug 1 mg 50 ug
Category
Type Proteins
Specific against other
Purity >98% as determined by SDS-PAGE
Sequence Amino acid sequence derived from human CD274 (NP_054862.1) (Met1-Thr239)was expressed with a 6 His tag at the C-terminus.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Programmed Cell Death 1 Ligand 1,PD-L1,PDCD1 Ligand 1,Programmed Death Ligand 1,B7 Homolog 1,B7-H1,CD274,B7H1,PDCD1L1,PDCD1LG1,PDL1
Available
Shipping Temperature
The product is shipped at ambient temperature.
Storage Conditions
Lyophilized Human CD274 protein product should be stored desiccated below -20C. Upon reconstitution, the protein should be stored at 4C between 2-7 days and for future use below -20C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
Molecular Weight
26.8 KD
Background
Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1 (PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. Plays a critical role in induction and maintenance of immune tolerance to self . As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function (By similarity). The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy.
Description
Recombinant Human CD274/PD-L1 protein expressed in HEK293 Cells.
Formulation
Lyophilized from sterile PBS, pH 7.4.
Precautions
The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.
Features & Benefits
Endotoxin: < 1.0 EU per ug of the protein as determined by the LAL method.
Usage Notes
Always centrifuge tubes before opening. It is recommended to reconstitute the lyophilized Human CD274/PD-L1 protein using the buffer we provided not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.
Preparation method
HEK293 Cells
Protein length
The recombinant human CD274 consists of 227 amino acids and predicts a molecular mass of 26.8 KD. It migrates as an approximately 33-40 KD band in SDS-PAGE under reducing conditions due to glycosylation.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close